Publication Policy

  1. Home
  2. Policy

Publication Policy

GENERAL

The editorial policies of IJBTCM follow the Principles of Transparency and Best Practice in Scholarly Publishing (joint statement by COPE, DOAJ, WAME, and OASPA) and, where relevant, the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals from ICMJE.

Open access

All published articles in IJBTCM are made freely available to read, download, and distribute immediately upon publication, given that the original source and authors are cited (Creative Commons Attribution License (CC BY 4.0)).

SUBMISSION, PEER REVIEW AND EDITORIAL PROCESS

The double blinded peer review and editorial processes are facilitated through email notifications.

General: Publication and authorship

  • All submitted papers are subject to a rigorous peer review process by at least two international reviewers who are experts in the scientific field of the particular paper.
  • The factors that are taken into account in review are relevance, soundness, significance, originality, readability and language.
  • The journals allow a maximum of two rounds of review of a manuscript. The ultimate responsibility for editorial decisions lies with the respective Subject Editor and, in some cases, with the Editor-in-Chief. All appeals should be directed to the Editor-in-Chief, who may decide to seek advice among the Subject Editors and Reviewers.
  • The possible decisions include: (1) Accept, (2) Minor revisions, (2) Major revisions, (3) Reject, but re-submission encouraged and (5) Reject.
  • If Authors are encouraged to revise and re-submit a submission, there is no guarantee that the revised submission will be accepted.
  • The paper acceptance is constrained by such legal requirements as shall then be in force regarding libel, copyright infringement and plagiarism.
  • No research can be included in more than one publication.

Responsibility of Authors

  • Authors are required to agree that their paper will be published in open access under the Creative Commons Attribution License (CC BY 4.0) license.
  • Authors must certify that their manuscripts are their original work.
  • Authors must certify that the manuscript has not previously been published elsewhere.
  • Authors must certify that the manuscript is not currently being considered for publication elsewhere.
  • Authors should submit the manuscript in linguistically and grammatically correct English and formatted in accordance with the journal’s Author Guidelines.
  • Authors must participate in the peer review process.
  • Authors are obliged to provide retractions or corrections of mistakes.
  • All Authors mentioned are expected to have significantly contributed to the research.
  • Authors must notify the Editors of any conflicts of interest.
  • Authors must identify all sources used in the creation of their manuscript.
  • Authors must report any errors they discover in their published paper to the Editors.
  • Authors should acknowledge all significant funders of the research pertaining to their article and list all relevant competing interests.
  • Other sources of support for publications should also be clearly identified in the manuscript, usually in an acknowledgement (e.g. funding for the article processing charge; language editing or editorial assistance).
  • The Corresponding author should provide the declaration of any conflicts of interest on behalf of all Authors. Conflicts of interest may be associated with employment, sources of funding, personal financial interests, membership of relevant organisations or others.

RESEARCH ETHICS

Neutrality to geopolitical disputes

General

The strict policy of IJBTCM is to stay neutral to any political or territorial dispute. Authors should depoliticize their studies by avoiding provoking remarks, disputable geopolitical statements and controversial map designations. In case that this is unavoidable, the journal reserves the right to mark such at least as disputable at or after publication, to publish editor's notes or to reject/retract the papers.

Authors' affiliations

IJBTCM does not take decisions regarding the actual affiliations of institutions. Authors are advised to provide their affiliation as indicated on the official internet site of their institution. Editors

Editorial decisions should not be affected by the origins of the manuscript, including the nationality, ethnicity, political beliefs, race, or religion of the authors. Decisions to edit and publish should not be determined by the policies of governments or other agencies outside of the journal itself.

Human and animal rights

The ethical standards in medical and pharmacological studies are based on the Helsinki declaration (1964, amended in 1975, 1983, 1989, 1996 and 2000) of the World Medical Association and the Publication Ethics Policies for Medical Journals of the World Association of Medical Journals (WAME).

Informed consent

Individual participants in studies have the right to decide what happens to the identifiable personal data gathered, to what they have said during a study or an interview, as well as to any photograph that was taken. Hence it is important that all participants gave their informed consent in writing prior to inclusion in the study. Identifying details (names, dates of birth, identity numbers and other information) of the participants that were studied should not be published in written descriptions, photographs, and genetic profiles unless the information is essential for scientific purposes and the participant (or parent or guardian if the participant is incapable) gave written informed consent for publication. Complete anonymity is difficult to achieve in some cases, and informed consent should be obtained if there is any doubt. If identifying characteristics are altered to protect anonymity, such as in genetic profiles, authors should provide assurance that alterations do not distort scientific meaning.

The following statement should be included in the article text in one of the following ways:

  • "Informed consent was obtained from all individual participants included in the study."
  • "Informed consent was obtained from all individuals for whom identifying information is included in this article." (In case some patients’ data have been published in the article or supplementary materials to it).

Conflict of interest

During the editorial process, the following relationships between editors and authors are considered conflicts of interest: Current colleagues, recent colleagues, recent co-authors, and doctoral students for which editor served as committee chair. During the submission process, the authors are kindly advised to identify possible conflicts of interest with the journal editors. After manuscripts are assigned to the handling editor, individual editors are required to inform the managing editor of any possible conflicts of interest with the authors. Journal submissions are also assigned to referees to minimize conflicts of interest. After manuscripts are assigned for review, referees are asked to inform the editor of any conflicts that may exist.

CORRECTIONS, RETRACTIONS, AND EDITORIAL EXPRESSIONS OF CONCERN

Appeals and open debate

We encourage academic debate and constructive criticism. Authors are always invited to respond to any editorial correspondence before publication. Authors are not allowed to neglect unfavorable comments about their work and choose not to respond to criticisms.
No Reviewer’s comment or published correspondence may contain a personal attack on any of the Authors. Criticism of the work is encouraged. Editors should edit (or reject) personal or offensive statements. Authors should submit their appeal on editorial decisions to the Editorial Office, addressed to the Editor-in-Chief or to the Managing Editor. Authors are discouraged from directly contacting Editorial Board Members and Editors with appeals.
Editors will mediate all discussions between Authors and Reviewers during the peer review process prior to publication. If agreement cannot be reached, Editors may consider inviting additional reviewers if appropriate.
The Editor-in-Chief will mediate all discussions between Authors and Subject Editors.
The journals encourage publication of open opinions, forum papers, corrigenda, critical comments on a published paper and the Author's response to criticism.

Misconduct

Research misconduct may include: (a) manipulating research materials, equipment or processes; (b) changing or omitting data or results such that the research is not accurately represented in the article; c) plagiarism. Research misconduct does not include honest error or differences of opinion. If misconduct is suspected, journal Editors will act in accordance with the relevant COPE guidelines.

Plagiarism and duplicate publication policy

A special case of misconduct is plagiarism, which is the appropriation of another person's ideas, processes, results or words without giving appropriate credit. Plagiarism is considered theft of intellectual property and manuscripts submitted to this journal which contain substantial unattributed textual copying from other papers will be immediately rejected. Editors are advised to check manuscripts for plagiarism via the iThenticate service by clicking on the "ïThenticate report" button. Journal providing a peer review in languages other than English (for example, Russian) may use other plagiarism checking services (for example, Antiplagiat).

Instances, when authors re-use large parts of their publications without providing a clear reference to the original source, are considered duplication of work. Slightly changed published works submitted in multiple journals is not acceptable practice either. In cases of plagiarism in an already published paper or duplicate publication, an announcement will be made on the journal publication page and a procedure of retraction will be triggered.

Responses to possible misconduct

All allegations of misconduct must be referred to the Editor-In-Chief. Upon the thorough examination, the Editor-In-Chief and deputy editors should conclude if the case concerns a possibility of misconduct. All allegations should be kept confidential and references to the matter in writing should be kept anonymous, whenever possible.

Should a comment on potential misconduct be submitted by the Reviewers or Editors, an explanation will be sought from the Authors. If it is satisfactory and the issue is the result of either a mistake or misunderstanding, the matter can be easily resolved. If not, the manuscript will be rejected or retracted and the Editors may impose a ban on that individual's publication in the journals for a certain period of time. In cases of published plagiarism or dual publication, an announcement will be made in both journals explaining the situation.

When allegations concern authors, the peer review and publication process for their submission will be halted until completion of the aforementioned process. The investigation will be carried out even if the authors withdraw the manuscript, and implementation of the responses below will be considered.

When allegations concern reviewers or editors, they will be replaced in the review process during the ongoing investigation of the matter. Editors or reviewers who are found to have engaged in scientific misconduct should be removed from further association with the journal, and this fact reported to their institution.

Retraction policies

Article retraction

According to the COPE Retraction Guidelines followed by this Journal, an article can be retracted because of the following reasons:

  • Unreliable findings based on clear evidence of a misconduct (e.g. fraudulent use of the data) or honest error (e.g. miscalculation or experimental error).
  • Redundant publication, e.g., findings that have previously been published elsewhere without proper cross-referencing, permission or justification.
  • Plagiarism or other kind of unethical research.

International Journal of Biotechnology and Clinical Medicine (IJBTCM) is a Peer Reviewed Journal with quarterly frequency.

Contact Us

© 2022 IJBTCM. All Rights Reserved